Lucid Diagnostics
LUCD
31 hedge funds and large institutions have $5.52M invested in Lucid Diagnostics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 12 closing their positions.
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
0.88% less ownership
Funds ownership: 7.35% → 6.48% (-0.88%)
3% less funds holding
Funds holding: 32 → 31 (-1)
39% less capital invested
Capital invested by funds: $9.09M → $5.52M (-$3.57M)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
+$263K |
| 2 |
Morgan Stanley
New York
|
+$109K |
| 3 |
Millennium Management
New York
|
+$53.9K |
| 4 |
E
Ergoteles
New York
|
+$49.5K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$34.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$813K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$137K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$111K |
| 4 |
State Street
Boston,
Massachusetts
|
-$103K |
| 5 |
BlackRock
New York
|
-$99.1K |
LUCD Hedge Fund Activity: Q2 2022 in Review
31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2022, worth a combined $5.52M — down 39% from $9.09M a quarter earlier.
Fund positioning in LUCD was balanced in Q2 2022: 12 funds opened new positions, 12 closed out, 5 added to existing stakes and 11 trimmed.
The largest buyer was Luminus Management, adding an estimated $263K. The largest seller was Putnam Investments, exiting entirely with an estimated $813K sold.
- 31 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2022, down from 32 in Q1 2022.
- Funds reported $5.52M of Lucid Diagnostics stock for Q2 2022, down 39% quarter-over-quarter.
- 12 funds opened new Lucid Diagnostics positions in Q2 2022 and 12 closed out, a net change of 0 holders.
- The largest Lucid Diagnostics buyer in Q2 2022 was Luminus Management, an estimated $263K added.
- The largest Lucid Diagnostics seller in Q2 2022 was Putnam Investments, an estimated $813K sold.
Based on aggregated 13F filings for Q2 2022.